Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Daiichi Sankyo
Harvard Business School
Argus Health
Cipla
Citi
Moodys
Healthtrust
Julphar

Generated: January 23, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for VTP-27999

« Back to Dashboard

US Patents for VTP-27999

Glossary
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
VTP-27999 ➤ Try a Free Trial Piperidine renin inhibitors Vitae Pharmaceuticals, Inc. (Fort Washington, PA) ➤ Try a Free Trial
VTP-27999 ➤ Try a Free Trial Salts of methyl 2-((R)-(3-chlorophenyl)((R)-1-((S)-2-(methylamino)-3-((R)-tetrahydro-2H-p- yran-3-yl)propylcarbamoyl)piperidin-3-yl)methoxy)ethylcarbamate Vitae Pharmaceuticals, Inc. (Fort Washington, PA) ➤ Try a Free Trial
VTP-27999 ➤ Try a Free Trial Piperidinyl carbamate intermediates for the synthesis of aspartic protease inhibitors Vitae Pharmaceuticals, Inc. (Fort Washington, PA) ➤ Try a Free Trial
VTP-27999 ➤ Try a Free Trial Piperidine renin inhibitors Vitae Pharmaceuticals, Inc. (Fort Washington, PA) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for VTP-27999

Glossary
Drugname Country Document Number Estimated Expiration Related US Patent
VTP-27999 Argentina 057890 2025-11-14 ➤ Try a Free Trial
VTP-27999 Argentina 062797 2025-11-14 ➤ Try a Free Trial
VTP-27999 Austria 520690 2025-11-14 ➤ Try a Free Trial
VTP-27999 Austria 538092 2025-11-14 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
US Department of Justice
Federal Trade Commission
Boehringer Ingelheim
Covington
Cerilliant
Queensland Health
Baxter
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2019 - 2020
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: